Theophylline Target Concentration in Severe Airways Obstruction — 10 or 20 mg/L?

SummaryThe optimal serum concentration of theophylline for the management of acute airways obstruction was evaluated by comparing the response to target concentrations at the extremes of the usual therapeutic range. 174 patients requiring intravenous theophylline were randomly assigned to a target concentration of 10 or 20 mg/L. Control of theophylline dosage using measured theophylline concentrations and evaluation of efficacy and toxicity was performed under double-blind conditions. 87 patients (50%) required hospital admission. Of these, 54 patients (62%) were followed throughout their hospital admission and reviewed at an outpatient clinic approximately 1 week after discharge. The duration of hospital stay, and rate and extent of improvement in peak expiratory flow rate were not different between the groups. There was significantly more toxicity in the 20 mg/L group. The initial target concentration for theophylline in the management of acute airway obstruction should be 10 mg/L under circumstances where concentration is used to control theophylline dosages.

[1]  R. Ogilvie,et al.  Rational intravenous doses of theophylline. , 1973, The New England journal of medicine.

[2]  A. Gelb,et al.  Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. , 1985, The American review of respiratory disease.

[3]  A. Sheffer,et al.  A multicenter trial of the prophylactic effect of ketotifen, theophylline, and placebo in atopic asthma. , 1985, Journal of Allergy and Clinical Immunology.

[4]  L B Sheiner,et al.  Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia. , 1978, The American review of respiratory disease.

[5]  F. Follath,et al.  Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline. , 1982, American Review of Respiratory Disease.

[6]  C. Slovis,et al.  Aminophylline therapy for acute bronchospastic disease in the emergency room. , 1991, Annals of internal medicine.

[7]  D. Niewoehner,et al.  Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. , 1987, Annals of internal medicine.

[8]  C C Peck,et al.  The randomized concentration-controlled trial: an evaluation of its sample size efficiency. , 1991, Controlled clinical trials.

[9]  B. Littenberg,et al.  A controlled trial of methylprednisolone in the emergency treatment of acute asthma. , 1986, The New England journal of medicine.

[10]  W. Busse,et al.  Theophylline--how much is enough? , 1986, The Journal of allergy and clinical immunology.

[11]  L. Sheiner,et al.  Understanding the Dose-Effect Relationship , 1981, Clinical pharmacokinetics.

[12]  T. Guarnieri,et al.  MULTIFOCAL ATRIAL TACHYCARDIA: A TOXIC EFFECT OF THEOPHYLLINE , 1985, The Lancet.

[13]  M. Aubier,et al.  A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. , 1989, The New England journal of medicine.

[14]  H. Teichtahl,et al.  Intravenous aminophylline confers no benefit in acute asthma treated with intravenous steroids and inhaled bronchodilators. , 1993, Australian and New Zealand journal of medicine.

[15]  L B Sheiner,et al.  Time and Theophylline Concentration Help Explain the Recovery of Peak Flow Following Acute Airways Obstruction , 1993, Clinical pharmacokinetics.